ImpediMed

ImpediMed Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of ImpediMed (IPD.AX) as of Nov 12, 2026 is 30.45. In the previous year, Days Inventory Outstanding (DIO) was 179.68 — a change of -83.05% (lower).

Days Inventory Outstanding

30.45

YoY

-83.05%

Last updated:

Days Inventory Outstanding (DIO) of ImpediMed is 2026 30.45 . Days Inventory Outstanding (DIO) of ImpediMed was 2025 179.68 . It decreases by -83.05% lower compared to the previous year.

The ImpediMed Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2019
326.81 AUD
Jan 1, 2020
16.93 AUD
Jan 1, 2021
6.59 AUD
Jan 1, 2022
14.13 AUD
Jan 1, 2023
11.83 AUD
Jan 1, 2024
210.83 AUD
Jan 1, 2025
179.68 AUD
Jan 1, 2026
30.45 AUD
The ImpediMed Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
30.45-83.05%
179.68-14.78%
210.83+1,682.65%
11.83-16.31%
14.13+114.53%
6.59-61.08%
16.93-94.82%
326.81-51.75%
677.27+88.59%
359.12+13.03%
317.73-29.64%
451.56+5.79%
426.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImpediMed Stock analysis

What does ImpediMed do? ImpediMed Ltd is an Australian company specializing in medical devices and technologies. They were founded in 1999 and have their headquarters in Brisbane, Australia. The company is a leading provider of bioimpedance measurement devices for the diagnosis, monitoring, and treatment of lymphatic, cardiac, and other medical conditions. They have a wide range of products used in various medical fields, including oncology, lymphology, and cardiology. Their main business model is based on the development and marketing of their bioimpedance measurement devices. They also provide training and support for medical personnel to optimize the use of their devices. ImpediMed specializes in the diagnosis and treatment of lymphedema in the oncology sector, particularly using their highly precise L-Dex® device. They also analyze body composition in the cardiology sector to determine the risk of heart diseases and develop personalized treatment approaches. In recent years, ImpediMed has expanded into the European market, particularly in lymphedema diagnosis and treatment. Overall, ImpediMed Ltd is an innovative company that focuses on medical devices and technologies for the diagnosis and monitoring of cardiac and lymphatic diseases. They provide important diagnostic capabilities to medical professionals and continue to focus on growth and expansion. ImpediMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImpediMed stock

Days Inventory Outstanding (DIO) of ImpediMed is 30.45 in 2026.

Days Inventory Outstanding (DIO) of ImpediMed changed from 179.68 to 30.45, representing a -83.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) ImpediMed since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s ImpediMed with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ImpediMed

All Key Metrics — ImpediMed